Monthly Archives: June 2008

Andreas Krebs is president of Wyeth Pharmaceuticals

June 30th, 2008|

Wyeth Pharmaceuticals, a division of Wyeth , announced the appointment of Andreas Krebs, 50, to president – Europe/Middle East/Africa and Canada, effective immediately. In this new role, Krebs will report to Joseph M. Mahady, president – Wyeth Pharmaceuticals, and senior vice president, Wyeth. 

Watson Launches Generic MARINOL(R) Capsules

June 30th, 2008|

Watson Pharmaceuticals, Inc. a leading specialty pharmaceutical company, under a supply agreement with Solvay Pharmaceuticals, Inc., Watson has launched the authorized generic version of dronabinol in the 2.5, 5 and 10 mg once daily dosage strengths.

US FDA approves PrandiMet tablet for type 2 diabetes

June 30th, 2008|

Sciele Pharma, Inc. and Novo Nordisk Inc. has received US Food and Drug Administration (FDA) approval for  PrandiMet (repaglinide and metformin HCl) tablets, the first and only fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, for the treatment of type 2 diabetes.

Grandix starts producing ReNerve from Strides US FDA facility

June 30th, 2008|

Grandix Pharmaceuticals Ltd, the Chennai based branded pharmaceutical marketing company, along with its parent company Strides Arcolab Ltd, Bangalore, has started manufacturing its brand 'ReNerve' (for diabetics neuropathy) from Strides US FDA facility.

Chugai Pharma launches hepatitis C information website

June 30th, 2008|

Japan based Chugai Pharmaceutical Co., Ltd. has launched of "C gatakanen ZERO," a website for providing the latest information on hepatitis C.

CCEA approves for drug R&D

June 28th, 2008|

The Cabinet Committee on Economic Affairs (CCEA) on 26th June, gave its approval for extending grants-in-aid to pharmaceutical companies for developing new drugs for neglected diseases such as tuberculosis, malaria, kala-azar, and filariasis. 

Sun Pharma files lawsuit against Taro Pharma in US

June 27th, 2008|

India’s Sun Pharmaceutical Industries said its subsidiary has exercised the option under its option agreement to acquire all the shares held by the controlling shareholders of Israel-based Taro Pharmaceuticals Industries.

Roche sets up international Postdoc Fellowship programme

June 27th, 2008|

Roche is setting up a new international Roche Postdoc Fellowship programme (RPF).

QIAGEN introduces Comprehensive Solution for Epigenetics

June 27th, 2008|

QIAGEN has launched EpiTect product portfolio for epigenetics which standardizes solutions covering all steps of epigenetic research processes in molecular diagnostics, pharma and life sciences.

Neurosurgeon Bags Patent for Cylindrical channel retractor

June 27th, 2008|

Dr Lokendra Singh, a senior neurosurgeon has bagged him a national patent for first designed a device using just a syringe and a hand glove used in any surgery as an emergency measure to remove a brain tumor.

Oracle launches global business unit on health sciences

June 27th, 2008|

Oracle has launched the formation of a new Global Business Unit focused on software applications for the health sciences industry.

Microbix to set up $200 mn flu vaccine facility in China

June 27th, 2008|

Canadian firm Microbix Biosystems has entered into a definitive agreement with the Hunan provincial government to establish a manufacturing facility in China that will produce influenza vaccine using Microbix’s Virusmax technology.

Kwang Dong to sell AsiaPharm’s cancer drug in Korea

June 27th, 2008|

Singapore-listed AsiaPharm, a specialty pharmaceutical group from China, has appointed Kwang Dong Pharmaceutical as the exclusive distributor for its oncology drug, CMNa, in South Korea.

Himachal ayurveda geriatric plan launched

June 27th, 2008|

Health and ayurveda minister Rajeev Bindal launched geriatric care campaign through ayurveda in Shimla.  Bindal said that 85 posts of ayurvedic doctors have been sanctioned in the state and very shortly 154 vacant posts would be filled up.

Good Translations Vital for Clinical Research Trials

June 27th, 2008|

L. N. Baijal, B.Pharm, is a communicator in Clinical Research Translations. Baijal, who also holds a Masters Degree in Advertising, Marketing & Public Relations….[English]

Centocor’s ustekinumab approved by USFDA for psoriasis

June 26th, 2008|

The Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) of the US Food and Drug Administration (FDA) has unanimously recommended the approval of Centocor’s ustekinumab, a new subcutaneous, investigational biologic therapy for the treatment of adult patients with moderate to severe plaque psoriasis.

Synapse Bio’s respiratory device gets USFDA approval

June 26th, 2008|

The US Food and Drug Administration has approved the NeuRx DPS RA/4 Respiratory Stimulation System, an implantable electronic device that stimulates the diaphragm and allows certain spinal cord injury patients to breathe for at least four hours a day without a mechanical ventilator.

Ranbaxy receives USFDA’s approval for Valganciclovir HCl tablets

June 26th, 2008|

Ranbaxy Laboratories got tentative approval from US FDA to manufacture and market Valganciclovir Hydrochloride tablets of 450 mg strengths.

Orchid gets Canadian nod for piperacillin/tazobactam injection

June 26th, 2008|

The Chennai-based pharma major, Orchid Chemicals & Pharmaceuticals Ltd (Orchid) has received approval from the Canadian TPD (Therapeutic Products Directorate) for its ANDS (Abbreviated New Drug Submission) Orchid Chemicals & Pharmaceuticals Ltd for injection.

NovaMed to market BioAlliance’s miconazole in China

June 26th, 2008|

Specialty Pharma company BioAlliance Pharma SA has entered into an exclusive licensing agreement with NovaMed Inc., under which NovaMed Pharma will receive the commercialization rights in China for Loramyc therapy.